Versant Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.7K | Buy |
|
|||||
|
2025
Q2 | $65K | Buy |
|
|||||
|
2025
Q1 | $45.2K | Buy |
|
|||||
|
2024
Q4 | $11.1K | Buy |
|
|||||
|
2024
Q3 | $4.84K | Sell |
|
|||||
|
2024
Q2 | $7.71K | Buy |
|
|||||
|
2024
Q1 | $965 | Hold |
|
|||||
|
2023
Q4 | $922 | Buy |
|
|||||
|
2023
Q3 | $450 | Sell |
|
|||||
|
2023
Q2 | $849 | Buy |
|
|||||
|
2023
Q1 | $397 | Sell |
|
|||||
|
2022
Q4 | $1.31K | Hold |
|
|||||
|
2022
Q3 | $1K | Hold |
|
|||||
|
2022
Q2 | $1K | Hold |
|
|||||
|
2022
Q1 | $1K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $0 | Buy |
|